https://scholars.lib.ntu.edu.tw/handle/123456789/507618
標題: | Circulating programmed death-1 as a marker for sustained high hepatitis b viral load and risk of hepatocellular carcinoma e95870 | 作者: | Cheng H.-Y. Kang P.-J. YA-HUI CHUANG Wang Y.-H. Jan M.-C. Wu C.-F. Lin C.-L. CHUN-JEN LIU Liaw Y.-F. Lin S.-M. PEI-JER CHEN Lee S.-D. MING-WHEI YU |
公開日期: | 2014 | 卷: | 9 | 期: | 11 | 起(迄)頁: | e95870 | 來源出版物: | PLoS ONE | 摘要: | Objective: Recent evidence indicates a crucial role of the immunoinhibitory receptor programmed death-1 (PD-1) in enforcing T-cell dysfunction during chronic viral infection and cancer. We assessed the impact of circulating soluble PD-1 (sPD-1) levels on long-term dynamics of hepatitis B virus (HBV) load and hepatocellular carcinoma (HCC) risk.Methods: In a case-cohort study on longitudinal analysis of viral load within a cohort of 2903 men chronically infected with HBV, followed up from baseline (1989-1992) through 2010, we determined sPD-1 levels in baseline plasma with enzymelinked immunosorbent assay from 126 men who subsequently developed HCC and 1155 men who did not develop HCC. To evaluate whether patients' characteristics involved the use of sPD-1 as a biomarker, sPD-1 was also tested in 614 newlydiagnosed patients with HBV-related HCC recruited from a multicenter study for comparison with the 1155 noncases in the case-cohort study.Results: Plasma quartile levels of sPD-1 were positively associated with HCC risk for men in the case-cohort analysis (vs. quartile 1: adjusted odds ratios [95% confidence intervals] for quartile 2-quartile 4 were 1.51 [0.75-3.03], 2.15 [1.12-4.13], and 2.29 [1.20-4.38], respectively), and in the case-control study regardless of age-of-onset and clinical stage. Furthermore, we found longitudinal effect of elevated sPD-1 levels to maintain higher viral load for 4 or more years, with greater and more prolonged effect among HBV genotype C- vs. non-C-infected participants. High levels of viral load and sPD-1 (vs. absence of both) was associated with a 6.29-fold increase in risk of HCC, and combining both conditions with HBV genotype C yielded an odds ratio of 30.47 with significant additive interaction (relative excess risk due to interaction: 27.08 [95% confidence interval58.76-45.41]).Conclusions: Our data suggest plasma sPD-1 as an important immune-related marker for assessment of HBV activity and HCC risk. ?heng et al. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/507618 | ISSN: | 1932-6203 | DOI: | 10.1371/journal.pone.0095870 | SDG/關鍵字: | alpha fetoprotein; hepatitis B surface antigen; programmed death 1 receptor; PDCD1 protein, human; programmed death 1 receptor; adult; aged; Article; cancer risk; cancer staging; cohort analysis; controlled study; hepatitis B; Hepatitis B virus genotype B; Hepatitis B virus genotype C; hepatitis C; human; liver cell carcinoma; liver cirrhosis; major clinical study; male; mixed infection; onset age; virus load; blood; Carcinoma, Hepatocellular; case control study; complication; Hepatitis B virus; Hepatitis B, Chronic; isolation and purification; Liver Neoplasms; middle aged; physiology; risk factor; virology; Adult; Aged; Carcinoma, Hepatocellular; Case-Control Studies; Cohort Studies; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Neoplasms; Male; Middle Aged; Programmed Cell Death 1 Receptor; Risk Factors; Viral Load |
顯示於: | 醫學檢驗暨生物技術學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。